- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cambridge Nutritional Sciences PLC (CNSL)
View current information about Omega Diagnostics (ODX) share price, performance and insights using our free LON: ODX stock exchange data.
Omega Diagnostics is a diagnostics company headquartered in the United Kingdom, specialising in the development, manufacturing, and distribution of in-vitro diagnostic (IVD) tests. With a focus on infectious diseases and autoimmune disorders, Omega Diagnostics offers a diverse portfolio of diagnostic products that aid in the detection and monitoring of various conditions. The company's expertise lies in areas such as allergy testing, food intolerance, autoimmune diseases, and infectious diseases like HIV, syphilis, and COVID-19.
Analyse historical data and ODX share price performance charts on this page. Our technical summary section provides analysis on Omega Diagnostics stock buy/sell indicators using real-time data (or discuss the Omega (ODX) share price with other investors in the LON ODX share price and sentiment chat forum). Use the dropdown to select a relevant stock exchange for the current LON: ODX stock or NASDAQ: ODX share price (ISIN: GB00B1VCP282) to enhance your trading decisions with our free investment data resources.
Omega Diagnostics is a diagnostics company headquartered in the United Kingdom, specialising in the development, manufacturing, and distribution of in-vitro diagnostic (IVD) tests. With a focus on infectious diseases and autoimmune disorders, Omega Diagnostics offers a diverse portfolio of diagnostic products that aid in the detection and monitoring of various conditions. The company's expertise lies in areas such as allergy testing, food intolerance, autoimmune diseases, and infectious diseases like HIV, syphilis, and COVID-19.
Analyse historical data and ODX share price performance charts on this page. Our technical summary section provides analysis on Omega Diagnostics stock buy/sell indicators using real-time data (or discuss the Omega (ODX) share price with other investors in the LON ODX share price and sentiment chat forum). Use the dropdown to select a relevant stock exchange for the current LON: ODX stock or NASDAQ: ODX share price (ISIN: GB00B1VCP282) to enhance your trading decisions with our free investment data resources.
London
Currency in GBP
3.37
-0.03(-0.88%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.35
3.70
52 wk Range
2.42
4.48
CNSL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CNSL is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.353.70
52 wk Range
2.424.48
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CNSL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Cambridge Nutritional Sciences Company Profile
Cambridge Nutritional Sciences plc, together with its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, North America, South/Central America, India, rest of Asia and the Far East, Africa, and the Middle East. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the FoodPrint brand. It also provides clinical analysis to the general public, clinics, and health professionals; and supplies Food Detective, a food sensitivity test. In addition, the company offers My Health Tracker, a health app for tracking symptoms, accessing FoodPrint results, and managing gut health; and CNS Lab, which provides laboratory services for food sensitivity. It serves the government, private hospitals and clinics, reference laboratories, nutritionists, naturopaths, and functional medicine healthcare professionals. The company was formerly known as Omega Diagnostics Group PLC and changed its name to Cambridge Nutritional Sciences plc in September 2023. Cambridge Nutritional Sciences plc is based in London, the United Kingdom.
Compare CNSL to Peers and Sector
Metrics to compare | CNSL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCNSLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 46.5x | −2.4x | −0.5x | |
PEG Ratio | 0.43 | 0.01 | 0.00 | |
Price/Book | 0.8x | 1.4x | 2.6x | |
Price / LTM Sales | 0.9x | 2.7x | 3.0x | |
Upside (Analyst Target) | 194.1% | 128.5% | 52.6% | |
Fair Value Upside | Unlock | 20.8% | 8.7% | Unlock |
Earnings
Latest Release
Nov 21, 2024
EPS / Forecast
-- / --
Revenue / Forecast
4.13M / --
FAQ
What Is the Cambridge Nutritional Sciences (CNSL) Share Price Today?
The live Cambridge Nutritional Sciences share price today is 3.37.
What Stock Exchange Does Cambridge Nutritional Sciences (CNSL) Trade On?
Cambridge Nutritional Sciences is listed and trades on the London Stock Exchange stock exchange.
What Is the Ticker (Stock Symbol) for Cambridge Nutritional Sciences?
The stock symbol (also called a 'ticker') for Cambridge Nutritional Sciences is "CNSL."
What Is the Current Cambridge Nutritional Sciences Market Cap?
As of today, Cambridge Nutritional Sciences market capitalisation is 8.02M.
What Is Cambridge Nutritional Sciences's (CNSL) Earnings Per Share (TTM)?
The Cambridge Nutritional Sciences EPS 0.00 (Trailing Twelve Months).
When Is the Next Cambridge Nutritional Sciences Earnings Date?
Cambridge Nutritional Sciences's next earnings report will be released on 10 Aug 2025.
Is CNSL a Buy or Sell From a Technical Analyst Perspective?
Based on today's Cambridge Nutritional Sciences moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Cambridge Nutritional Sciences Stock Split?
Cambridge Nutritional Sciences has split 3 times. (See the CNSL stock split history page for full effective split date and price information.)
How Many Employees Does Cambridge Nutritional Sciences Have?
Cambridge Nutritional Sciences currently has 94 employees.
What is the current trading status of Cambridge Nutritional Sciences (CNSL)?
As of 23 Jun 2025, Cambridge Nutritional Sciences (CNSL) is trading at a price of 3.37, with a previous close of 3.40. The stock has fluctuated within a day range of 3.35 to 3.70, while its 52-week range spans from 2.42 to 4.48.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.